S.C. Pediatric Oncohematology U
Principal Investigator (PI)/Coordinator: Prof. Franca Fagioli
Team
- Prof. Franca Fagioli, Full Professor, Head of Research Team
- Dr. Paola Quarello, Senior lecturer
- Dr. Katia Mareschi, Technician
- Dr. Aloe Adamini, Research Fellow
- Dr. Elena Marini, Research Fellow
- Dr. Celeste Cagnazzo, Research Fellow
- Dr. Alessia Giovanna Santa Banche Niclot, PhD Candidate
The group included also 18 Medical Executive of NHS, 6 Biologist of NHS and 1 Pharmacist of NHS.
PI contacts
Prof. Franca Fagioli
E-mail: franca.fagioli@unito.it
Phone: +39 0113131660
Webex Room
Ospedale Infantile Regina Margherita, Piazza Polonia 94, 10126 Torino
Research Activities
The Pediatric Oncohematology has numerous national and international collaborations: it is one of the main AIEOP centers (Italian Association of Pediatric Oncohematology) with about 150 new diagnoses per year; it is a member of the ITCC (Innovative Therapies for Children with Cancer) and it is included into ERN PedCan (European Reference Network for Pediatric Cancer). Regarding the field of hemopoietic stem cell transplantation, a transplant program is active at the Center which also acts as the Coordinator Center for the Metropolitan Transplant Center of Turin (CTMT). The CTMT is included in the EBMT (European Bone Marrow Transplantation) network and it is accredited by JACIE (Joint Accreditation Committee-ISCT & EBM) and National Transplant Center. The Transplant Center belonging to the Pediatric Oncohematology is also authorized starting from 2020 to administer the most advanced cell therapies, such as CAR-T cells.
Within these networks, it promotes and participates in numerous interventional and observational clinical research studies, including early phase (AIFA certified center for phase I). There are also many active research projects with particular focus on preclinical research for new therapeutic approaches for sarcomas, genomic analysis of sarcomas, validations for the expansion of cell therapy products for clinical use and germline analysis of the main cancer predisposing syndromes in childhood and adolescence.